US stock screener
Every US-listed company we cover, ranked by what it reported to the SEC. Figures come from each company’s own filings (P/E and dividend yield combine SEC share counts and TTM results with a daily price snapshot). Click a column to sort, or open a company for its full statements with per-figure provenance.
All sectorsTechnologyFinancialsHealthcareConsumer DiscretionaryConsumer StaplesEnergyIndustrialsMaterialsUtilitiesReal EstateCommunication Services
558 companies in Healthcare · page 4 of 6
| Company | Sector | Market cap | Revenue (FY) | Rev growth | Net margin | ROE | P/E (TTM) | Div yield |
|---|---|---|---|---|---|---|---|---|
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | Healthcare | $14.9M | $129.9M | 14.1% | -10.5% | -19.8% | — | — |
| Niagen Bioscience, Inc. (NAGE) | Healthcare | $270.4M | $129.4M | 29.9% | 13.4% | 22.7% | 16.2 | — |
| LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) | Healthcare | $171.8M | $128.9M | 0.5% | -30.0% | — | — | — |
| Xencor Inc (XNCR) | Healthcare | $1.45B | $125.6M | 13.7% | -73.2% | -14.5% | — | — |
| Monte Rosa Therapeutics, Inc. (GLUE) | Healthcare | $2.01B | $123.7M | 63.5% | -31.2% | -16.6% | — | — |
| Atara Biotherapeutics, Inc. (ATRA) | Healthcare | $77.8M | $120.8M | -6.3% | 27.1% | — | — | — |
| Outset Medical, Inc. (OM) | Healthcare | $76.6M | $119.5M | 5.1% | -68.3% | -64.3% | — | — |
| GYRE THERAPEUTICS, INC. (GYRE) | Healthcare | $662.2M | $116.6M | 10.2% | 8.5% | 6.9% | — | — |
| ORASURE TECHNOLOGIES INC (OSUR) | Healthcare | $265.1M | $115.0M | -38.1% | -59.8% | -20.2% | — | — |
| AGENUS INC (AGEN) | Healthcare | $232.4M | $114.2M | 10.4% | -2.7% | — | 3.5 | — |
| ImmunityBio, Inc. (IBRX) | Healthcare | $7.87B | $113.3M | 668.3% | — | — | — | — |
| Anika Therapeutics, Inc. (ANIK) | Healthcare | $201.7M | $112.8M | -5.9% | -9.6% | -7.6% | — | — |
| GEOSPACE TECHNOLOGIES CORP (GEOS) | Healthcare | $91.8M | $110.8M | -18.3% | -8.8% | -7.7% | — | — |
| UroGen Pharma Ltd. (URGN) | Healthcare | $2.07B | $109.8M | 21.4% | — | — | — | — |
| Century Therapeutics, Inc. (IPSC) | Healthcare | $387.8M | $109.2M | 1556.8% | -8.8% | -6.0% | — | — |
| MANNATECH INC (MTEX) | Healthcare | $8.5M | $108.0M | -8.3% | -14.1% | — | — | — |
| Theravance Biopharma, Inc. (TBPH) | Healthcare | $873.8M | $107.5M | 66.9% | 98.5% | 35.7% | 7.6 | — |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | Healthcare | $740.1M | $106.5M | 350.9% | 78.2% | 53.8% | 6.3 | — |
| Zymeworks Inc. (ZYME) | Healthcare | $1.70B | $106.0M | 38.9% | -76.6% | -30.2% | — | — |
| Owlet, Inc. (OWLT) | Healthcare | $154.0M | $105.7M | 35.4% | -37.5% | — | — | — |
| Sanara MedTech Inc. (SMTI) | Healthcare | $233.7M | $103.1M | 19.0% | -36.4% | -633.5% | — | — |
| SUTRO BIOPHARMA, INC. (STRO) | Healthcare | $391.1M | $102.5M | 65.2% | — | — | — | — |
| Beta Bionics, Inc. (BBNX) | Healthcare | $785.2M | $100.3M | 53.9% | -73.0% | -25.5% | — | — |
| NeuroPace Inc (NPCE) | Healthcare | $497.1M | $100.0M | 25.1% | -21.5% | -112.8% | — | — |
| Butterfly Network, Inc. (BFLY) | Healthcare | $1.78B | $97.6M | 19.0% | -79.0% | -39.3% | — | — |
| BIOLIFE SOLUTIONS INC (BLFS) | Healthcare | $1.43B | $96.2M | 28.9% | -4.8% | -1.2% | — | — |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | Healthcare | $1.26B | $95.1M | 59.0% | — | -50.7% | — | — |
| SIGA TECHNOLOGIES INC (SIGA) | Healthcare | $225.9M | $94.6M | -31.8% | 24.6% | 11.7% | 11.7 | 19.2% |
| Pulmonx Corp (LUNG) | Healthcare | $51.1M | $90.5M | 8.0% | -59.7% | -99.8% | — | — |
| VASO Corp (VASO) | Healthcare | $33.4M | $89.1M | 2.7% | 1.8% | 5.3% | 19.0 | — |
| Ceribell, Inc. (CBLL) | Healthcare | $678.8M | $89.1M | 36.1% | -60.0% | -34.4% | — | — |
| BIODESIX INC (BDSX) | Healthcare | $218.9M | $88.5M | 24.1% | -39.8% | — | — | — |
| CYTOKINETICS INC (CYTK) | Healthcare | $11.16B | $88.0M | 376.6% | — | — | — | — |
| HARVARD BIOSCIENCE INC (HBIO) | Healthcare | $27.6M | $86.5M | -8.1% | -65.5% | -412.8% | — | — |
| LakeShore Biopharma Co., Ltd. (LSBCF) | Healthcare | — | $85.7M | 6.0% | -16.3% | -20.0% | — | — |
| STANDARD BIOTOOLS INC. (LAB) | Healthcare | $320.4M | $85.3M | -6.2% | -87.8% | -17.7% | 4.1 | — |
| DELCATH SYSTEMS, INC. (DCTH) | Healthcare | $432.6M | $85.2M | 129.1% | 3.2% | 2.4% | 1253 | — |
| 4D Molecular Therapeutics, Inc. (FDMT) | Healthcare | $572.9M | $85.2M | 230194.6% | — | -27.7% | — | — |
| ARS Pharmaceuticals, Inc. (SPRY) | Healthcare | $595.8M | $84.3M | -5.5% | — | -149.9% | — | — |
| Nurix Therapeutics, Inc. (NRIX) | Healthcare | $2.45B | $84.0M | 54.0% | — | -49.1% | — | — |
| IRADIMED CORP (IRMD) | Healthcare | $1.20B | $83.8M | 14.4% | 26.8% | 23.8% | 51.4 | 1.3% |
| Arcturus Therapeutics Holdings Inc. (ARCT) | Healthcare | $170.3M | $82.0M | -46.1% | -80.2% | -30.7% | — | — |
| FITLIFE BRANDS, INC. (FTLF) | Healthcare | $96.4M | $81.5M | 26.4% | 7.8% | 14.5% | 60.4 | — |
| MeiraGTx Holdings plc (MGTX) | Healthcare | $1.13B | $81.4M | 144.6% | — | — | — | — |
| ADC Therapeutics SA (ADCT) | Healthcare | $161.5M | $81.4M | 14.9% | — | — | — | — |
| TELA Bio, Inc. (TELA) | Healthcare | $31.8M | $80.3M | 15.8% | -48.4% | -615.1% | — | — |
| Eton Pharmaceuticals, Inc. (ETON) | Healthcare | $1.19B | $80.0M | 104.9% | -5.8% | -17.6% | — | — |
| Sight Sciences, Inc. (SGHT) | Healthcare | $255.7M | $77.4M | -3.1% | -49.7% | -60.1% | — | — |
| Burning Rock Biotech Ltd (BNR) | Healthcare | $99.7M | $77.2M | 9.2% | -10.3% | -10.3% | — | — |
| CytomX Therapeutics, Inc. (CTMX) | Healthcare | $744.5M | $76.2M | -44.8% | -22.8% | -17.5% | — | — |
| Autolus Therapeutics plc (AUTL) | Healthcare | $389.9M | $75.4M | 644.9% | — | -161.4% | — | — |
| AbCellera Biologics Inc. (ABCL) | Healthcare | $1.82B | $75.1M | 160.6% | — | -15.1% | — | — |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | Healthcare | $1.60B | $74.7M | 26.9% | — | -57.0% | — | — |
| COMPUGEN LTD (CGEN) | Healthcare | $235.5M | $72.8M | 161.1% | 48.6% | 34.4% | — | — |
| BICYCLE THERAPEUTICS PLC (BCYC) | Healthcare | — | $72.6M | 105.8% | — | -35.9% | — | — |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | Healthcare | $524.6M | $72.3M | 153.5% | -8.5% | -3.0% | — | — |
| AVITA Medical, Inc. (RCEL) | Healthcare | $141.9M | $70.9M | 10.9% | -68.5% | — | — | — |
| Viridian Therapeutics, Inc.\DE (VRDN) | Healthcare | $2.13B | $70.8M | 23359.9% | — | -47.4% | — | — |
| EDAP TMS SA (FOCL) | Healthcare | $220.4M | $70.5M | 1.6% | -41.5% | -150.7% | — | — |
| Black Diamond Therapeutics, Inc. (BDTX) | Healthcare | $107.2M | $70.0M | — | 32.0% | 19.9% | — | — |
| Personalis, Inc. (PSNL) | Healthcare | $1.30B | $69.6M | -17.7% | — | -31.1% | — | — |
| ROCKWELL MEDICAL, INC. (RMTI) | Healthcare | $25.8M | $69.3M | -31.8% | -7.7% | -14.4% | — | — |
| Vir Biotechnology, Inc. (VIR) | Healthcare | $1.58B | $68.6M | -7.6% | — | -57.2% | — | — |
| Intellia Therapeutics, Inc. (NTLA) | Healthcare | $1.56B | $67.7M | 16.9% | — | -61.5% | — | — |
| Kura Oncology, Inc. (KURA) | Healthcare | $935.7M | $67.5M | 25.2% | — | -160.0% | — | — |
| Spero Therapeutics, Inc. (SPRO) | Healthcare | $67.2M | $66.8M | 39.2% | 12.8% | 14.5% | 4.3 | — |
| PRO DEX INC (PDEX) | Healthcare | $170.6M | $66.6M | 23.7% | 13.5% | 24.5% | 14.8 | — |
| EXAGEN INC. (XGN) | Healthcare | $119.6M | $66.6M | 19.7% | -30.0% | -114.3% | — | — |
| AYTU BIOPHARMA, INC (AYTU) | Healthcare | $23.4M | $66.4M | 1.8% | -20.4% | -71.5% | — | — |
| ENANTA PHARMACEUTICALS INC (ENTA) | Healthcare | $379.8M | $65.3M | -3.4% | — | -126.5% | — | — |
| Concord Medical Services Holdings Ltd (CCM) | Healthcare | $17.5M | $65.0M | 26.6% | -20.4% | -5.0% | — | — |
| Electromed, Inc. (ELMD) | Healthcare | $327.2M | $64.0M | 17.0% | 11.8% | 17.4% | 33.5 | — |
| Nuvation Bio Inc. (NUVB) | Healthcare | $2.26B | $62.9M | 699.0% | — | -66.9% | — | — |
| Tango Therapeutics, Inc. (TNGX) | Healthcare | $4.50B | $62.4M | 48.3% | — | -29.3% | — | — |
| Meihua International Medical Technologies Co., Ltd. (MHUAF) | Healthcare | $7.5M | $61.8M | -36.2% | 11.0% | 3.6% | — | — |
| Journey Medical Corp (DERM) | Healthcare | $196.0M | $61.2M | 11.1% | -18.7% | -35.9% | — | — |
| Fortress Biotech, Inc. (FBIO) | Healthcare | $117.9M | $61.2M | 11.1% | 11.1% | 11.0% | — | — |
| ALPHA PRO TECH LTD (APT) | Healthcare | $52.3M | $59.1M | 2.3% | 6.0% | 5.7% | 15.1 | — |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | Healthcare | $85.1M | $56.9M | 13.5% | 8.3% | 124.6% | — | — |
| CVRx, Inc. (CVRX) | Healthcare | $135.1M | $56.7M | 10.4% | -94.1% | -135.6% | — | — |
| 908 Devices Inc. (MASS) | Healthcare | $291.7M | $56.2M | 17.7% | 34.7% | 13.6% | — | — |
| NEKTAR THERAPEUTICS (NKTR) | Healthcare | $2.34B | $55.2M | -43.9% | — | -182.6% | — | — |
| INTEGRATED BIOPHARMA INC (INBP) | Healthcare | $5.0M | $54.4M | 8.0% | 1.5% | 4.0% | — | — |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | Healthcare | $2.14B | $54.0M | 48.0% | — | -34.6% | — | — |
| Q32 Bio Inc. (QTTB) | Healthcare | $456.9M | $53.7M | — | 55.5% | 71.0% | — | — |
| Invivyd, Inc. (IVVD) | Healthcare | $179.5M | $53.4M | 110.5% | -98.2% | -21.7% | — | — |
| Apyx Medical Corp (APYX) | Healthcare | $164.7M | $52.8M | 9.9% | -21.2% | -75.6% | — | — |
| Protalix BioTherapeutics, Inc. (PLX) | Healthcare | $191.0M | $52.7M | -1.2% | -12.5% | -13.7% | 13.2 | — |
| IRIDEX CORP (IRIX) | Healthcare | $16.0M | $52.7M | 8.2% | -8.4% | -90.1% | — | — |
| XOMA Royalty Corp (XOMA) | Healthcare | $710.2M | $52.1M | 83.1% | 60.8% | — | 25.6 | 1.1% |
| OCULAR THERAPEUTIX, INC (OCUL) | Healthcare | $1.88B | $52.0M | -18.5% | — | -40.6% | — | — |
| LENSAR, Inc. (LNSR) | Healthcare | $70.7M | $51.7M | 12.4% | -66.4% | — | — | — |
| CARLSMED, INC. (CARL) | Healthcare | $299.6M | $50.5M | 85.9% | -58.7% | -30.0% | — | — |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | Healthcare | $1.02B | $49.8M | 729.9% | — | -46.8% | — | — |
| Gossamer Bio, Inc. (GOSS) | Healthcare | $70.7M | $48.5M | -57.7% | — | — | — | — |
| SHOULDER INNOVATIONS, INC. (SI) | Healthcare | $467.2M | $47.3M | 49.6% | -85.3% | -28.7% | — | — |
| Protagonist Therapeutics, Inc (PTGX) | Healthcare | $8.64B | $46.0M | -89.4% | — | -21.2% | — | — |
| Septerna, Inc. (SEPN) | Healthcare | $1.42B | $46.0M | 4174.5% | — | -12.8% | — | — |
| TriSalus Life Sciences, Inc. (TLSI) | Healthcare | $267.8M | $45.2M | 53.4% | -86.9% | — | — | — |
| FENNEC PHARMACEUTICALS INC. (FENC) | Healthcare | $352.6M | $44.6M | -6.1% | -21.8% | -27.5% | — | — |
Want more than a table?
Sign in to screen with custom filters (growth, ROIC, insider buying, short interest and 30+ more metrics), compare peers side by side, and get filing-grounded answers with citations. Free to start.
Start freeFundamentals from SEC EDGAR (public domain), as reported; valuation columns combine SEC filings with market data and are blanked where the two sources disagree. Informational only. Not investment advice.